Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy

Molecular Medicine Today
P D EmanuelR P Castleberry

Abstract

Juvenile myelomonocytic leukemia is a rare but deadly myeloproliferative disorder of early childhood that infrequently progresses to acute leukemia. The pathogenesis of this leukemia has been linked to deregulated signal transduction, resulting in growth factor hypersensitivity. Several other myeloproliferative disorders appear to share growth factor hypersensitivity as a common pathophysiological mechanism and thus this leukemia serves as an important model. New treatment modalities, such as retinoid therapy, are emerging for juvenile myelomonocytic leukemia. Further understanding of deregulated signal transduction should pave the way for even more rationally designed therapy for this leukemia and related disorders.

References

Jun 1, 1978·The Journal of Pediatrics·J L Bader, R W Miller
Feb 11, 1991·The Journal of Clinical Investigation·C H DaiH S Gilbert
Mar 1, 1989·Japanese Journal of Cancer Research : Gann·H TsudaM Terada
Oct 1, 1988·The Journal of Clinical Investigation·G C BagbyE McCall
Jun 13, 1974·The New England Journal of Medicine·J F Prchal, A A Axelrad
Dec 22, 1994·The New England Journal of Medicine·R P CastleberryR J Gualtieri
Dec 16, 1993·Nature·M S Boguski, F McCormick
Mar 3, 1994·The New England Journal of Medicine·G M Brodeur

❮ Previous
Next ❯

Citations

Feb 21, 2008·Cancer Metastasis Reviews·Gordon ChanBenjamin G Neel
Feb 19, 2002·British Journal of Haematology·Franklin O SmithUNKNOWN National Marrow Donor Program
Oct 16, 1999·British Journal of Haematology·J MiyauchiS Mizutani
Oct 16, 1999·British Journal of Haematology·H HasleK R Schultz
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Stephane WongOwen N Witte
May 7, 2002·Journal of Pediatric Hematology/oncology·Adonis LorenzanaPeter D Emanuel
Nov 11, 1999·British Journal of Haematology·P D Emanuel
Jul 30, 2011·Journal of Signal Transduction·Xia Liu, Cheng-Kui Qu
Sep 11, 2014·Wiener medizinische Wochenschrift·Klaus Geissler
Sep 25, 2009·British Journal of Haematology·Paola De FilippiCesare Danesino
Dec 2, 2008·Best Practice & Research. Clinical Haematology·Jasmine C WongKevin Shannon
Apr 22, 2005·British Journal of Haematology·Marco TartagliaAndrea Biondi
Aug 2, 2005·European Journal of Medical Genetics·Marco Tartaglia, Bruce D Gelb
Nov 2, 2005·Pediatric Blood & Cancer·Jennifer O LauchleKevin Shannon
Jun 16, 2001·Seminars in Cancer Biology·K M ShannonN Killeen
Sep 7, 2001·The Journal of Clinical Investigation·Y ZhangD W Clapp
Mar 11, 2000·Molecular Cell·R A BirnbaumK M Shannon
Sep 16, 2014·Acta Pharmacologica Sinica·Rong-Jun HeZhong-Yin Zhang
Nov 11, 2003·Journal of Pediatric Hematology/oncology·David B WilsonRobert J Hayashi
Dec 17, 2003·Current Opinion in Hematology·Marco TartagliaMignon L Loh
Apr 2, 2008·The Journal of Chemical Physics·V I KalikmanovT Kraska
Mar 5, 2009·Physical Review Letters·Roberto BenziSauro Succi
Mar 3, 2007·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Sara FurlanGian Carlo Rossi
Mar 4, 2000·Journal of Biomolecular Structure & Dynamics·G La PennaD Genest
May 24, 2013·The Journal of Chemical Physics·Edgar M Blokhuis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.